IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -99.5% | 1,000 | -99.5% | 0.00% | -100.0% |
| Q3 2021 | $2,110,000 | -6.8% | 211,064 | -6.3% | 0.04% | +5.7% |
| Q2 2021 | $2,265,000 | -34.6% | 225,360 | -35.9% | 0.04% | -30.0% |
| Q1 2021 | $3,464,000 | – | 351,348 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hartree Partners, LP | 1,285,000 | $12,875,700,000 | 3.00% |
| Wealthspring Capital LLC | 231,182 | $2,317,000 | 0.50% |
| KRYGER CAPITAL Ltd | 385,240 | $3,860,000 | 0.22% |
| Schechter Investment Advisors, LLC | 210,692 | $2,111,000 | 0.19% |
| Sage Mountain Advisors LLC | 89,180 | $894,000 | 0.11% |
| Context Capital Management, LLC | 115,053 | $1,153,000 | 0.09% |
| Magnetar Financial LLC | 784,909 | $7,865,000 | 0.08% |
| ARISTEIA CAPITAL, L.L.C. | 350,000 | $3,507,000 | 0.06% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 36,569 | $366,000 | 0.05% |
| Bulldog Investors, LLP | 15,000 | $150,000 | 0.04% |